文献速递皮肤肿瘤

IFN-γ信号使黑色素瘤细胞对BH3模拟物敏感

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.
PubMed 文献 · J Invest Dermatol · 2023-02-01

该研究评估了PD-1抑制剂治疗后进展的黑色素瘤转移灶来源的短期细胞系(PD1 PROG细胞),发现IFN-γ通过改变凋亡调节因子MCL-1、NOXA和BAK的积累与相互作用使黑色素瘤细胞凋亡致敏;加入促凋亡BH3模拟物药物可使PD1 PROG细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。

要点

  • IFN-γ通过改变MCL-1、NOXA和BAK的积累与相互作用使黑色素瘤细胞凋亡致敏。
  • BH3模拟物药物使PD1 PROG黑色素瘤细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。
  • 该发现为黑色素瘤联合治疗提供了可转化策略。

核心结论

  • IFN-γ信号使黑色素瘤细胞对BH3模拟物敏感,为黑色素瘤联合治疗提供了可转化策略。

研究设计与样本

  • 研究评估了PD-1抑制剂治疗后进展的黑色素瘤转移灶来源的短期黑色素瘤细胞系(称为PD1 PROG细胞)。

主要发现

  • IFN-γ通过促进凋亡调节因子MCL-1、NOXA和BAK的积累与相互作用改变,使黑色素瘤细胞凋亡致敏。
  • 加入促凋亡BH3模拟物药物使PD1 PROG黑色素瘤细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunotherapy targeting PD-1 and/or CTLA4 leads to durable responses in a proportion of patients with melanoma. However, many patients will not respond to these immune checkpoint inhibitors, and up to 60% of responding patients will develop treatment resistance. We describe a vulnerability in melanoma driven by immune cell activity that provides a pathway towards additional treatment options. This study evaluated short-term melanoma cell lines (referred to as PD1 PROG cells) derived from melanoma metastases that progressed on PD-1 inhibitor-based therapy. We show that the cytokine IFN-γ primes melanoma cells for apoptosis by promoting changes in the accumulation and interactions of apoptotic regulators MCL-1, NOXA, and BAK. The addition of pro-apoptotic BH3 mimetic drugs sensitized PD1 PROG melanoma cells to apoptosis in response to IFN-γ or autologous immune cell activation. These findings provide translatable strategies for combination therapies in melanoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Ming Z, Lim SY, Stewart A, et al. IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics. J Invest Dermatol. 2023. PMID: 36736995. doi:10.1016/j.jid.2023.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。